Pharma CEOs Defend Drug Pricing Practices at Senate Hearing Amid Calls for Reform
CEOs from Johnson & Johnson, Merck, and Bristol Myers Squibb testified before the Senate Health, Education, [...]
Kyverna Therapeutics Raises $319 Million in IPO, Advances Autoimmune Cell Therapy Research
Kyverna Therapeutics, under CEO Peter Maag, Ph., has recently completed a $319 million Initial Public Offering [...]
Study Challenges Efficacy of High-Dose Naloxone in Opioid Overdose Survival, Raises Concerns Over Cost and Withdrawal Symptoms
A study published in the CDC's Morbidity and Mortality Weekly Report found no significant survival advantage [...]
Eli Lilly Settles Lawsuit with Minnesota to Cap Insulin Prices at $35 and Donate to Clinics
Eli Lilly has agreed to a settlement to provide low-cost insulin to Minnesota patients, addressing a [...]
Gilead Halts Magrolimab Blood Cancer Development After Increased Mortality Risk
Gilead Sciences is halting the development of magnolia for blood cancer, including acute myeloid leukemia (AML) [...]
Joshua Boger Takes Chair at CervoMed, Eyes Potential Breakthrough in Dementia Treatment with Neflamapimod
Joshua Boger, the former CEO of Vertex Pharmaceuticals, has selectively accepted a new role as chair [...]
House Hearing Addresses Drug Shortages and Manufacturing Challenges in the U.S.
At a House Ways and Means Committee hearing, the issue of chronic drug shortages in the [...]
AstraZeneca Invests $300 Million in New Cell Therapy Facility in Maryland, Creating Over 150 Jobs
AstraZeneca announced a $300 million investment in a new facility in Rockville, Maryland, dedicated to discovering [...]
Key Insights from the 2025 Medicare Advantage Proposals: A Cautious Approach in an Election Year
The 2025 Medicare Advantage (MA) proposals introduced by CMS indicate a cautious approach by the Biden [...]
The Rise of GLP-1 Influencers: Celebrity Endorsements and Social Media’s Role in the Ozempic Weight Loss Craze
The "Ozempic craze" refers to the growing popularity of GLP-1 drugs for weight loss, driven by [...]
Keytruda Surpasses Comirnaty to Become World’s Top-Selling Drug in 2023
Merck’s Keytruda has emerged as the world’s top-selling drug in 2023, with sales reaching $25 billion, [...]
Publicis Health Agrees to $350 Million Settlement Over Opioid Crisis Involvement
Publicis Health has agreed to a $350 million settlement to address its involvement in the opioid [...]
Medicare Begins Price Negotiations Under Inflation Reduction Act, Pharma Companies Stay Silent
The Centers for Medicare & Medicaid Services (CMS) has initiated Medicare price negotiations for the first [...]
CDC Study Finds Latest Covid-19 Booster 54% Effective Against Infection
The CDC reported that the latest COVID-19 booster is about 54% effective against infection, including the [...]
FDA Plans Major Reforms to Advisory Committee Process, Aiming for Enhanced Expert Involvement
The FDA is planning significant reforms to its advisory committee process, as announced by Commissioner Rob [...]
Pharma Giants Novo Nordisk, GSK, and Novartis Report Robust 2023 Earnings, Eye Growth in 2024
Year-end earnings for 2023 have been reported by major pharma companies Novo Nordisk, GSK, and Novartis, [...]
Link Discovered Between Cadaveric Hormone Treatment and Early-Onset Alzheimer’s
In a striking discovery reported in Nature Medicine, a group of patients who received cadaver-derived growth [...]
Pfizer’s Muted Enthusiasm for Abrysvo Amid Stiff Competition and Strategic Shifts
At the J.P. Morgan Healthcare Conference, Pfizer's CEO Albert Bourla labeled the launch of the RSV [...]
Emerging Biotechs Lead 2024’s Most Anticipated Drug Launches
The key points and takeaways from the report on the most anticipated new drugs of 2024 [...]
Supreme Court to Review Mifepristone Access in Landmark Abortion Case
The Supreme Court is set to hear arguments on March 26 about access to the abortion [...]
Incorporating SOGIE Data in Health Systems: Addressing LGBTQ+ Health Disparities
Researchers are advocating for the inclusion of SOGIE (Sexual Orientation, Gender Identity, and Expression) data in [...]
Global Growth and Challenges in the Respiratory Oxygen Delivery Devices Market (2023-2030)
The global Respiratory Oxygen Delivery Devices market is projected to grow from US$12.78 billion in 2023 [...]
Saudi Arabia Launches National Biotech Strategy to Establish Global Leadership by 2030
Saudi Arabia has initiated a national biotech strategy as part of its Vision 2030 project, aiming [...]
Invasive Breast Cancer and Mortality Risks after Non-Screen Detected Ductal Carcinoma In Situ: A 28-Year Cohort Study in England
This study, published in BMJ in 2024, investigates the long-term risks of invasive breast cancer and [...]
Chronic Covid in Immunocompromised Patients: Risks and Implications for Viral Evolution
Recent research in "Science Translational Medicine" sheds light on chronic COVID-19, a condition where the virus [...]